Literature DB >> 18520234

The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation.

Kwan Man1, Chung Mau Lo, Jiang Wei Xiao, Kevin T Ng, Bai Shun Sun, Irene O Ng, Qiao Cheng, Chris K Sun, Sheung Tat Fan.   

Abstract

OBJECTIVE: To test the hypothesis that acute phase small-for-size graft injury may promote late phase tumor recurrence after liver transplantation. SUMMARY BACKGROUND DATA: Living donor liver transplantation may provide the substantial intention-to-treat survival advantage for liver cancer patients. However, liver grafts from live donors are almost always small for size for adult recipients. Besides, tumor recurrence and metastasis after living donor liver transplantation have been reported.
METHOD: An orthotopic Buffalo rat liver transplantation model using whole (100%, group W) and small-for-size grafts (50%, group S) was applied. Hepatoma cells were injected into the grafts after reperfusion. Comparison was made as regards acute phase graft injury and tumor growth together with cell proliferation (Ki67), angiogenesis (vascular endothelial growth factor), stellate cell activation (alpha-smooth muscle actin), and cell signaling pathway related to migration and invasion (Rac, rho-associated, coiled-coil containing protein kinase, and proline-rich tyrosine kinase 2). Invasiveness of the tumors developed was further assessed after their direct implantation into livers of nude mice.
RESULTS: Liver tumors developed earlier and faster in group S with significantly greater tumor burden [hepatic replacement area: 61%; range, 47%-72%; vs. 18%; 12%-27%; P = 0.001] and tumor cell proliferation (92% vs. 59%; P = 0.0021) in a more invasive growth pattern with a higher incidence of venous invasion (91.7% vs. 25%; P = 0.003) and more frequent hepatic stellate cell activation. There was upregulation of protein expression of Rac/rho-associated, coiled-coil containing protein kinase/proline-rich tyrosine kinase 2/vascular endothelial growth factor signaling in group S. When implanted into livers of nude mice, tumors from group S had a higher incidence of local (70% vs. 0%; P = 0.003) and lung metastasis (50% vs. 0%; P = 0.033). This phenotype was consistent with their ultrastructural features linking to angiogenesis and invasiveness.
CONCLUSION: Significant activation of cell signaling pathways leading to tumor invasion and migration in small-for-size liver grafts promotes tumor growth and metastasis after liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18520234     DOI: 10.1097/SLA.0b013e31816ffab6XXX

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  28 in total

Review 1.  Effect of liver regeneration on malignant hepatic tumors.

Authors:  Ji-Hua Shi; Pål-Dag Line
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

Review 2.  A review of current status of living donor liver transplantation.

Authors:  Gil-Chun Park; Gi-Won Song; Deok-Bog Moon; Sung-Gyu Lee
Journal:  Hepatobiliary Surg Nutr       Date:  2016-04       Impact factor: 7.293

Review 3.  Living vs. deceased-donor liver transplantation for patients with hepatocellular carcinoma.

Authors:  Kohei Ogawa; Yasutsugu Takada
Journal:  Transl Gastroenterol Hepatol       Date:  2016-05-04

Review 4.  Living-donor vs deceased-donor liver transplantation for patients with hepatocellular carcinoma.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  World J Hepatol       Date:  2014-09-27

5.  Impact of operative and peri-operative factors on the long-term prognosis of primary liver cancer patients undergoing hepatectomy.

Authors:  Li-Ning Xu; Ying-Ying Xu; De-Wei Gao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28

Review 6.  Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients.

Authors:  Xiang-Qian Gu; Wei-Ping Zheng; Da-Hong Teng; Ji-San Sun; Hong Zheng
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

7.  The impact of posthepatectomy liver failure on the recurrence of hepatocellular carcinoma.

Authors:  Kohta Iguchi; Etsuro Hatano; Kenya Yamanaka; Shiro Tanaka; Kojiro Taura; Shinji Uemoto
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

8.  Impact of hepatic arterial reconstruction on orthotopic liver transplantation in the rat.

Authors:  Tomohide Hori; Lindsay B Gardner; Florence Chen; Ann-Marie T Baine; Toshiyuki Hata; Shinji Uemoto; Justin H Nguyen
Journal:  J Invest Surg       Date:  2012-05-09       Impact factor: 2.533

9.  Inhibition of transforming growth factor-beta/Smad signaling improves regeneration of small-for-size rat liver grafts.

Authors:  Zhi Zhong; Shigeki Tsukada; Hasibur Rehman; Christopher J Parsons; Tom P Theruvath; Richard A Rippe; David A Brenner; John J Lemasters
Journal:  Liver Transpl       Date:  2010-02       Impact factor: 5.799

10.  Monocytic MDSC mobilization promotes tumor recurrence after liver transplantation via CXCL10/TLR4/MMP14 signaling.

Authors:  Hui Liu; Chang Chun Ling; Wai Ho Oscar Yeung; Li Pang; Jiang Liu; Jie Zhou; Wei Yi Zhang; Xiao Bing Liu; Tak Pan Kevin Ng; Xin Xiang Yang; Chung Mau Lo; Kwan Man
Journal:  Cell Death Dis       Date:  2021-05-14       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.